跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
6-a
首页
药物
6-a
6-a
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Specific binding agents for KSHV vIL-6 that neutralize a biological activity
US 6939547 B2
申请人: US HEALTH
优先权: 2003
US
9 件公开
ADMINISTRATION OF A SELECTIVE IL-6-TRANS-SIGNALLING INHIBITOR
EP 3226888 B1
申请人: FERRING BV
优先权: 2014
CN
EP
US
WO
7 件公开
VECTORS ENCODING A GLUCOSE-6-PHOSPHATASE (G6PASE-A) FOR GENE THERAPY
EP 3913060 A1
申请人: GENETHON
优先权: 2020
CN
EP
US
WO
7 件公开
Derivatives of pyrimido[6, 1-A]isoquinolin-4-one
US 7378424 B2
申请人: VERONA PHARMA PLC
优先权: 1999
US
7 件公开
Formulations of 6-(2-hydroxy-2-methylpropxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-A]pyridine-3-carbonitrile
US 10786489 B2
申请人: LOXO ONCOLOGY INC
优先权: 2017
CN
US
6 件公开
OXAZEPINE COMPOUNDS COMPRISING A 6-AZA MOIETY AND USES THEREOF
EP 4605399 A1
申请人: GENENTECH INC
优先权: 2022
CN
EP
US
WO
5 件公开
6-aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agents
US 7285555 B2
申请人: WYETH CORP
优先权: 2003
CN
US
5 件公开
Synthetic method of 6-hodroisoindolo[2,1-a]indole compound
CN 107602562 A
申请人: ZHAO DONGMIN
优先权: 2013
CN
5 件公开
Method for inhibiting a microvascular complication by administering IL-6
US 8003090 B2
申请人: MERCK SERONO SA
优先权: 2004
EP
US
WO
4 件公开
Separation of 6-aminocapronitrile and hexamethylenediamine from a mixture comprising hexamethylenediamine, 6-aminocapronitrile and tetrahydroazepine
US 2006058545 A1
申请人: INVISTA NORTH AMERICA SARL
优先权: 2004
CN
EP
US
4 件公开
第 1 / 10 页
上一页
下一页
药物
反馈